Rokos Capital Management LLP Bausch Health Companies Inc. Transaction History

Rokos Capital Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $6.31 Million - $8.62 Million	-812,682 Reduced 54.18%	687,318 $7.29 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $1.59 Million - $2 Million	243,529 Added 19.38%	1,500,000 $12 Million
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $3.85 Million - $4.86 Million	-500,000 Reduced 28.47%	1,256,471 $10.3 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $10 Million - $15.5 Million	1,756,471 New	1,756,471 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $4.71 Million - $9.47 Million	1,028,019 New	1,028,019 $7.34 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Rokos Capital Management LLP with notifications on news.